79 related articles for article (PubMed ID: 15150440)
41. Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults.
Richter HE; Lohrer HD; Hieber L; Kellerer AM; Lengfelder E; Bauchinger M
Carcinogenesis; 1999 Dec; 20(12):2247-52. PubMed ID: 10590215
[TBL] [Abstract][Full Text] [Related]
42. Microsatellite analysis of synchronous and metachronous tumors: a tool for double primary tumor and metastasis assessment.
Tang M; Pires Y; Schultz M; Duarte I; Gallegos M; Wistuba II
Diagn Mol Pathol; 2003 Sep; 12(3):151-9. PubMed ID: 12960697
[TBL] [Abstract][Full Text] [Related]
43. Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma.
Schäffler A; Palitzsch KD; Seiffarth C; Höhne HM; Riedhammer FJ; Hofstädter F; Schölmerich J; Rüschoff J
Eur J Clin Invest; 1998 Oct; 28(10):838-44. PubMed ID: 9792998
[TBL] [Abstract][Full Text] [Related]
44. Loss of heterozygosity and microsatellite instability as predictive markers among Iranian esophageal cancer patients.
Forghanifard MM; Vahid EE; Dadkhah E; Gholamin M; Noghabi SB; Ghahraman M; Farzadnia M; Abbaszadegan MR
Iran J Basic Med Sci; 2016 Jul; 19(7):726-33. PubMed ID: 27635196
[TBL] [Abstract][Full Text] [Related]
45. Strong Correlation of Abnormal Serum and Urinary Iodine Levels with Papillary Thyroid Cancer: A Case-control Study.
Xiu C; He Q; Zhao HJ; Yuan ZN; Guo LH; Wang FQ; Yang XG; Tian QS; Sun QH; Miao SS; Sun J; Fan LJ; Jia SS
Biomed Environ Sci; 2020 Jan; 33(1):62-67. PubMed ID: 32029061
[No Abstract] [Full Text] [Related]
46. Microsatellite instability (MSI) markers in thyroid carcinoma.
Mastronikolis N; Chrysovergis A; Tsiambas E; Kyrodimos E
J BUON; 2021; 26(3):1169. PubMed ID: 34268987
[No Abstract] [Full Text] [Related]
47. [Etiology and clinico-morphological classification of thyroid tumors].
Kovalenko AE
Klin Khir; 1999; (10):41-4. PubMed ID: 10584523
[No Abstract] [Full Text] [Related]
48. [Iodine deficiency states and thyroid cancer].
Van Middlsvort L
Probl Endokrinol (Mosk); 1992; 38(5):56-9. PubMed ID: 1480595
[No Abstract] [Full Text] [Related]
49. [Progress of risk factors for thyroid tumors].
Liu S; Song JY; Zhang JQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Aug; 54(8):897-901. PubMed ID: 32842321
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
[TBL] [Abstract][Full Text] [Related]
51. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Genutis LK; Tomsic J; Bundschuh RA; Brock PL; Williams MD; Roychowdhury S; Reeser JW; Frankel WL; Alsomali M; Routbort MJ; Broaddus RR; Wakely PE; Phay JE; Walker CJ; de la Chapelle A
Thyroid; 2019 Apr; 29(4):523-529. PubMed ID: 30747051
[TBL] [Abstract][Full Text] [Related]
52. Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.
Read ML; Fong JC; Modasia B; Fletcher A; Imruetaicharoenchoke W; Thompson RJ; Nieto H; Reynolds JJ; Bacon A; Mallick U; Hackshaw A; Watkinson JC; Boelaert K; Turnell AS; Smith VE; McCabe CJ
Oncogene; 2017 Sep; 36(37):5296-5308. PubMed ID: 28504713
[TBL] [Abstract][Full Text] [Related]
53. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
[TBL] [Abstract][Full Text] [Related]
54. Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: an immunohistochemical study.
Giaginis C; Michailidi C; Stolakis V; Alexandrou P; Tsourouflis G; Klijanienko J; Delladetsima I; Theocharis S
Med Sci Monit; 2011 Feb; 17(3):BR81-90. PubMed ID: 21358597
[TBL] [Abstract][Full Text] [Related]
55. Large proportion of low frequency microsatellite-instability and loss of heterozygosity in pheochromocytoma and endocrine tumors detected with an extended marker panel.
Kupka S; Haack B; Zdichavsky M; Mlinar T; Kienzle C; Bock T; Kandolf R; Kroeber SM; Königsrainer A
J Cancer Res Clin Oncol; 2008 Apr; 134(4):463-71. PubMed ID: 17828419
[TBL] [Abstract][Full Text] [Related]
56. Microsatellite instability and its correlation with clinicopathological features in a series of thyroid tumors prevalent in iodine deficient areas.
Vaish M; Mishra A; Kaushal M; Mishra SK; Mittal B
Exp Mol Med; 2004 Apr; 36(2):122-9. PubMed ID: 15150440
[TBL] [Abstract][Full Text] [Related]
57. Microsatellite instability as prognostic marker in bladder tumors: a clinical significance.
Vaish M; Mandhani A; Mittal RD; Mittal B
BMC Urol; 2005 Jan; 5():2. PubMed ID: 15647110
[TBL] [Abstract][Full Text] [Related]
58. Assessment of microsatellite instability in bladder and thyroid malignancies.
Vaish M; Mishra SK; Mandhani A; Mittal RD; Mittal B
Teratog Carcinog Mutagen; 2003; Suppl 1():255-65. PubMed ID: 12616616
[TBL] [Abstract][Full Text] [Related]
59. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
Naidoo R; Tarin M; Chetty R
Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
[TBL] [Abstract][Full Text] [Related]
60. The clinical relevance of microsatellite alterations in head and neck squamous cell carcinoma: a critical review.
De Schutter H; Spaepen M; Mc Bride WH; Nuyts S
Eur J Hum Genet; 2007 Jul; 15(7):734-41. PubMed ID: 17473833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
